Clinical trial
A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on…
NCT00308451 · Nutrition 21, Inc., Industry · Completed
Key facts
| NCT number | NCT00308451 |
|---|---|
| Title | A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM |
| Official title | "A Randomized, Double Blinded, Placebo Controlled, Parallel Arm, Study to Evaluate the Improvement in Glycemic Control After Daily Administration of Chromium Picolinate and Biotin in Patients With Type 2 Diabetes Mellitus" |
| Lead sponsor | Nutrition 21, Inc., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Chromium Picolinate (600 mcg Cr+3) + biotin (2 mg) |
| Enrollment | 40 |
| Start date | Nov 1, 2003 |
| Completion | Apr 1, 2004 |
| First posted | Mar 29, 2006 |
| Last update posted | Mar 29, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: